Skip to main content

Time in Range News

Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in the target range, usually between 70 and 180 mg/dl.

The diaTribe team was in Barcelona for the 55 th Annual Meeting of the European Association for the Study of Diabetes. Check out our biggest highlights from the...
The tool for people with diabetes to use with their healthcare professionals will launch in early 2020, extending CGM further! Features include fully disposable...
What is it like having a sibling with diabetes, and what can someone do to support their sibling with diabetes? 20-year-old Alexandra Varon shares insight on having a...
What I've Learned From 70,000 Hours Wearing CGM - A Video Presentation at Thriveabetes 2019
Diabetes advocates, Renza and Grumpy, share the importance of #LanguageMatters and the consequences of “grading” diabetes management
This study, now recruiting 350 participants, will examine the safety of the MiniMed 780G Advanced Hybrid Closed Loop System in people with type 1 diabetes (7+ Years)
A new paper suggests that as people with diabetes increase their time in range, healthcare costs decrease
The automated insulin delivery system with Dexcom’s G6 aims to launch in the US by the end of the year for those ages 14+; first system with auto boluses and no...
FDA approves WellDoc’s BlueStar app (24/7 diabetes management coaching and support) for use in type 1 diabetes. BlueStar insights also now incorporate data from Dexcom...
As 2019 comes to an end, we reflect on a year of hope and growth, with immense gratitude for our community. In 2020 we will continue to focus on helping people with...
New updates include time-in-range goals, heart health benefits of GLP-1 agonist Trulicity, and recommendation of GLP-1 agonist Victoza for children and teens with type 2...
Control-IQ Hybrid Closed Loop on track to launch in the US by the end of 2019 for those ages 14 and older; first system with automatic correction boluses and no...
New updates include the recommendation of GLP-1 agonists and SGLT-2 inhibitors for heart and kidney protection, earlier combination therapy in type 2 diabetes, GLP-1...
En el Mes Nacional de la Salud de las Minorías, el autor comparte la historia de su diagnóstico de diabetes tipo 2
The diaTribe team was on the ground in Madrid, Spain to cover the latest news in diabetes technology from ATTD. Here are our top highlights from the conference!
The ADA Scientific Sessions starts later this week – we've highlighted some of the most important presentations and posters for you to look forward to
In exciting news, Tandem announced expanded clearance for the hybrid closed loop Control-IQ. The system is now available for children ages 6-13
The Time in Range Coalition aims to help millions of people by promoting time in range in diabetes care
The G6 Pro includes several exciting new features and is expected to start shipping next week!
Mark Harmel, MPH, CDCES, discusses how his clinic is moving to telemedicine in the time of COVID-19 and how to share data from many diabetes devices

Pages